CKD: Progression and Diabetes (2001)
Standards of diabetes care seek to provide physicians and other health care professionals who treat people with diabetes with a means to:
- Set treatment goals
- Assess the quality of diabetes treatment provided
- Identify areas where more attention or self-management training is needed
- Define timely and necessary referral patterns to appropriate specialists
Patients with diabetes with a means to:
- Assess the quality of medical care they receive
- Develop expectations for their role in the medical treatment
- Compare their treatment outcomes with standard goals
None specifically mentioned.
None specifically mentioned.
Recruitment:
Methods of study inclusion not detailed in this article.
Design
Consensus Report
Blinding Used (if applicable):
Not applicable.
Intervention (if applicable):
A grading system developed by the American Diabetes Association and modeled after existing methods was utilized to clarify and codify the evidence that forms the basis for the recommendations.
Statistical Analysis:
Statistical analysis not completed in this report.
Timing of Measurements
Not applicable.
Dependent Variables
Not applicable.
Independent Variables
Not applicable.
Control Variables
Initial N: Number of studies included not detailed in this consensus report, 91 references cited
Attrition (Final N): Not applicable.
Age: Not mentioned
Ethnicity: Not mentioned
Other relevant demographics:
Anthropometry:
Location: Worldwide studies
Glycemic control for people with diabetes
Normal
mg/dl |
Goal
mg/dl |
Action needed
mg/dl |
|
Whole Blood Average Preprandial | <100 | 80-120 | <80/>140 |
Average Bedtime | <110 | 100-140 | <100/>160 |
Plasma values Average Preprandial | <110 | 90-130 | <90/>150 |
Average Bedtime | <120 | 110-150 | <110/>180 |
HbA1c (%) | <6 | <7 | >8 |
Achieving blood glucose goals in patients requires comprehensive education in self-management, and for most, intensive treatment programs. Such programs include the following components according to individual patient need:
- Appropriate frequency of self-monitoring of blood glucose (SMBG)
- Medical nutrition therapy (MNT)
- Regular exercise
- Physiologically based insulin regimens
- Less-complex insulin regimens or oral glucose-lowering agents in some type 2 patients
- Instruction in the prevention and treatment of hypoglycemia and other acute and chronic complications
- Continuing education and reinforcement
- Period assessment of treatment goals
Type 1 Diabetes Mellitus
The desired outcome of glycemic control is to achieve maximum prevention of complications with due regard for patient safety. To achieve these goals with intensive management, the following may be necessary:
- Frequent SMBG (3-4 times/day)
- Medical nutrition therapy
- Education in self-management and problem solving
- Possible hospitalization for initiation of therapy.
Type 2 Diabetes Mellitus
Improved blood glucose control reduces the risk of developing retinopathy and nephropathy and possibly reduces neuropathy. Overall microvascular complications rate was decreased by 25% in patients receiving intensive therapy versus conventional therapy (UKPDS study).
- Daily SMBG important for those on insulin or sulfonylureas to monitor for and prevent hypoglycemia.
- The role of SMBG in stable diet-treated patients is not known.
- Treatment should emphasize diabetes management as a multiple risk factor approach including MNT, exercise, weight reduction if indicated, use of oral glucose-lowering agents and/or insulin.
All Types of Diabetes
Initial Visit
Medical history, physical exam, laboratory evaluation and management plan.
Management plan:
- Short & long-term goals
- Medications
- Individualized nutrition recommendations and instructions preferably by RD familiar with components of diabetes MNT
- Recommendations for lifestyle changes (exercise, smoking cessation)
- Patient/family education for self-management
- Monitoring instructions: SMBG, urine ketones, and use of a record system.
- Annual comprehensive dilated eye and visual exam by an ophthalmologist or optometrist for all patients >10 years who have had diabetes for 3-5 yr, all patients after 30 yrs of age or if symptomatic
- Consultation for podiatry services as indicated
- Consultation for specialized services as indicated
- Agreement on continuing support, follow-up, return appointments
- Instructions on when and how to contact the physician or other health care team members when patient unable to solve problems
Continuing Care Visit frequency
- Patients beginning treatment with MNT or oral glucose-lowering agents may need to be contacted as often as weekly until reasonable glucose control is achieved and they are competent to conduct the treatment program.
- Patients should generally be seen at least quarterly until achievement of treatment goals.
- Once patients have met treatment goals, semiannual visits are recommended.
Evaluation of management plan
The management plan should be reviewed at each regular visit to determine progress in meeting goals and to identify problems:
- Control of blood glucose levels
- Assessment of complications
- Control of blood pressure
- Control of dyslipidemia
- Nutrition assessment
- Frequency of hypoglycemia
- Adherence to all aspects of self-care
- Evaluation of exercise regimen
- Follow-up of referrals
- Psychosocial adjustment
- Knowledge of diabetes and self-management skills reassessed at least annually.
Children and Adolescents
Diabetes care for children <18 yr of age should be provided by a team that can deal with the special medical, educational, nutritional and behavioral issues
Glycemic goals may need to be modified for children <6 to 7 yr of age since children are unable to recognize the symptoms of hypoglycemia. Sick day management rules need to be taught to prevent severe hyperglycemia and DKA requiring hospitalization.
A nutritional assessment should be performed at diagnosis or at least annually thereafter by an individual experienced with the nutrition needs of the growing child and behavioral issues that have an impact on adolescent diets.
Diabetes is a chronic illness that requires continuing medical care and education to prevent acute complications and to reduce the risk of long-term complications. People with diabetes should receive their treatment and care from a physician-coordinated team. Such teams include, but are not limited to health care professionals with expertise and a special interest in diabetes:
- Physicians
- Nurses
- Dietitians
- Mental health professionals
Not-for-profit |
|
Medical Nutrition Therapy is an important component of the initial and ongoing treatment for individuals with diabetes mellitus.
MNT should be initiated when the diagnosis of diabetes is made with weekly follow-up visits with the team including the RD until blood glucose goals are met.
For continuous care, semi-annual visits with the team should include a nutritional assessment and appropriate nutrition counseling by an RD. Counseling would include an evaluation of knowledge and skills in self-management and adjustment of diet and physical activity to meet these blood glucose goals and to prevent acute and chronic complications of poor diabetes control.
Quality Criteria Checklist: Review Articles
|
|||
Relevance Questions | |||
1. | Will the answer if true, have a direct bearing on the health of patients? | Yes | |
2. | Is the outcome or topic something that patients/clients/population groups would care about? | Yes | |
3. | Is the problem addressed in the review one that is relevant to dietetics practice? | Yes | |
4. | Will the information, if true, require a change in practice? | Yes | |
Validity Questions | |||
1. | Was the question for the review clearly focused and appropriate? | Yes | |
2. | Was the search strategy used to locate relevant studies comprehensive? Were the databases searched and the search termsused described? | ??? | |
3. | Were explicit methods used to select studies to include in the review? Were inclusion/exclusion criteria specified andappropriate? Wereselectionmethods unbiased? | ??? | |
4. | Was there an appraisal of the quality and validity of studies included in the review? Were appraisal methodsspecified,appropriate, andreproducible? | Yes | |
5. | Were specific treatments/interventions/exposures described? Were treatments similar enough to be combined? | Yes | |
6. | Was the outcome of interest clearly indicated? Were other potential harms and benefits considered? | Yes | |
7. | Were processes for data abstraction, synthesis, and analysis described? Were they applied consistently acrossstudies and groups? Was thereappropriate use of qualitative and/or quantitative synthesis? Was variation in findings among studies analyzed? Were heterogeneity issued considered? If data from studies were aggregated for meta-analysis, was the procedure described? | ??? | |
8. | Are the results clearly presented in narrative and/or quantitative terms? If summary statistics are used, are levels ofsignificance and/or confidence intervals included? | Yes | |
9. | Are conclusions supported by results with biases and limitations taken into consideration? Are limitations ofthe review identified anddiscussed? | Yes | |
10. | Was bias due to the review's funding or sponsorship unlikely? | Yes | |